American Fusion(TM) Inc. (AMFN) Reports 151 Pending U.S.

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
43
American Fusion(TM) Inc. (AMFN) Reports 151 Pending U.S. Patent Applications, Advances Texatron(TM) Fusion Testing, Plans Uplisting


- The latest patent filings cover variations in Texatron(TM) confinement structures, chamber geometries, fuel injection, and electromagnetic components.

- The company is pursuing further Texatron(TM) testing at a university facility while preparing to establish a dedicated, company-controlled testing site.

- American Fusion(TM) has identified a property for the proposed facility and negotiated principal terms, but the transaction remains subject to closing conditions.

- The company is preparing for a potential national exchange uplisting, with the Texas Stock Exchange under consideration alongside NYSE and NASDAQ.

American Fusion(TM) (OTCBQ: AMFN), a developer of next-generation fusion energy technologies, has reported 21 additional U.S. patent applications, bringing its pending portfolio to 151, as the Texas-based fusion developer advances plans for further Texatron(TM) testing and prepares for a potential move to a national securities exchange.

The company’s September 22 corporate update outlined three areas of activity: intellectual property protection, testing infrastructure and capital-markets preparation (https://nnw.fm/qjvFV). The new applications expand coverage around the Texatron(TM) platform, including alternative confinement structures and component arrangements. The filings described in the update include quartz and aluminum configurations, rifled toroidal chambers, electromagnetic foils, ridge-mounted coils and helium-3/deuterium fuel-injection systems.

American Fusion(TM) says its intellectual property strategy is intended to protect a family of potential Texatron(TM) Fusion Engine(TM) designs rather than a single reactor configuration. The company argues that securing a broad range of technical approaches may become more important as engineering work progresses and it engages with prospective commercial counterparties. The applications are pending and remain subject to examination by the U.S. Patent and Trademark Office.

“Our intellectual property strategy is designed to protect not merely a single fusion device, but a family of Texatron(TM) Fusion Engines(TM) and the technologies that may support multiple sizes, configurations, applications and future generations of the platform,” said Brent Nelson, Executive Chairman of American Fusion(TM). “We believe that intellectual property may ultimately represent one of American Fusion’s(TM) most important long-term corporate assets.”

A second focus is the company’s testing program. American Fusion(TM) continues to pursue testing at a university facility while planning a dedicated site under its own control. Management says the facility could provide greater flexibility over scheduling and diagnostic instrumentation. The company has identified a property and negotiated principal terms and a purchase price. It expects to enter escrow through an affiliate, but the transaction remains subject to customary closing conditions. American Fusion(TM) said it would provide further details in a Current Report on Form 8-K as required.

A company-controlled facility would complement, rather than replace, outside scientific and engineering relationships. The update did not provide a detailed schedule for the site’s completion or specify when particular testing milestones would be reached.

The Texatron(TM) program remains in development and engineering validation. The company’s longer-term objective is to establish a modular fusion-energy platform, but the update did not announce a new demonstration of sustained fusion power or commercial electricity production.

The third area is a potential uplisting from OTCQB to a national securities exchange. American Fusion(TM) is evaluating the Texas Stock Exchange (TXSE) as a preferred possibility, while also considering the New York Stock Exchange and NASDAQ. Management cited the company’s Texas headquarters and development activity as factors in its interest in TXSE.

The company believes it meets TXSE’s initial listing criteria apart from the minimum bid-price requirement, and says it may qualify under a $200 million market-capitalization standard. Depending on the share price at the time of an application, a reverse stock split may be considered to address the bid-price requirement.

American Fusion(TM) says work completed during 2026, including audited financial statements, SEC reporting status, current periodic reporting and OTCQB qualification, has helped build the infrastructure for a possible national listing. Any uplisting would still require the company to meet the selected exchange’s rules and receive its approval.

The company also disclosed receiving several financing term sheets from funds contemplating capital in connection with a potential uplisting and the advancement of Texatron(TM) commercialization. It is evaluating those proposals alongside other alternatives. No definitive financing agreement has been executed, leaving the amount, structure and availability of any future capital uncertain.

The update also noted that Chief Executive Officer Brent Nelson and members of management were scheduled to visit the NYSE on September 28 for an interview with New to The Street and meetings with banks and institutional investors.

For more information, visit the company’s website at www.AmericanFusionEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to AMFN are available in the company’s newsroom at https://nnw.fm/AMFN

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer

American Fusion Inc (AMFN) Stock Research Links

AMFN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 34

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 39

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 31

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 45

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 41

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Celebrating Green Leaders: 2024 IGIHOF Induction Ceremony Details

Updated Category News Views 276

Celebrating the Newest Inductees into the Green Industry The International Green Industry Hall of Fame (IGIHOF) is gearing up for its annual induction ceremony, where it will honor nine remarkable individuals and organizations dedicated to advancing ecological sustainability. This year, the event will take place within the environment of innovative learning at the...

Continue Reading
Governor Advocates for Controlled Substances Decriminalization

Updated Category News Views 48

Governor Advocates for Controlled Substances Decriminalization Puerto Rico’s Governor Pedro Pierluisi Urrutia has made a compelling argument for decriminalizing the consumption of all controlled substances. His stance primarily addresses the pressing fentanyl crisis affecting communities across the island. Governor Pierluisi highlighted, "I have said since the 90s that...

Continue Reading
Odyssey Marine Exploration: Navigating Stock Market Challenges

Updated Category News Views 221

Recent Trends in Odyssey Marine Exploration Stock Odyssey Marine Exploration, Inc. (NASDAQ: OMEX) has seen its stock price fluctuate significantly in recent times. After an arbitration award involving the company and the United Mexican States was announced, the stock experienced a sharp decline, which has sparked concerns about its future path. Decoding the Arbitration...

Continue Reading
Decent Holding Inc. Unveils US$8 Million Offering for Growth

Updated Category News Views 101

Decent Holding Inc. Announced Its New Offering In a significant move within the wastewater treatment sector, Decent Holding Inc. (NASDAQ: DXST) shared exciting news about their latest financing initiative. The company has introduced a registered offering amounting to US$8 million. This offering involves 13,333,333 Class A ordinary shares priced at US$0.60 each, along with...

Continue Reading
Nexxen Strengthens Data Strategies with Eric Solomon's Leadership

Updated Category News Views 208

Nexxen Appoints Eric Solomon to Drive Data Strategy In a significant move for the advertising technology landscape, Nexxen (NASDAQ: NEXN) has welcomed Eric Solomon as its new Senior Vice President for Product – Data. This appointment underscores Nexxen's dedication to a data-driven approach that aims to enhance growth and success for advertisers and media companies...

Continue Reading